preclinical models
Learn about common challenges and proper maintenance practices for catheterized rodent models.
| 4 min read
Preclinical systems such as patient-derived xenografts are providing unprecedented insight into tumor biology and helping bridge the gap between discovery and clinical translation.
| 8 min read
As nearly 90 percent of drugs fail in human trials, researchers are turning to patient-derived cells, engineered tissues, and AI to better predict human responses and reduce costly late-stage failures.
Explore how advanced functional human organ models improve preclinical drug testing and toxicity evaluation.
| 2 min read
A collaboration designed to overcome the limitations of cold-chain logistics by enabling safe, viable, and ready-to-use transport of microbiome-sensitive 3D skin constructs to customers worldwide.
| 3 min read
The therapy exploits the properties of a neutrophil-derived enzyme to selectively kill tumor cells while preserving healthy immune cells.
| 2 min read
The updated brand identity underscores nearly 30 years of scientific leadership and a growing portfolio designed for modern preclinical discovery.
| 8 min read
Jo Varshney explains how human-relevant models and mechanistic simulations are transforming early-stage drug discovery and development.
| 5 min read
Animal and cell culture models have fallen short in kidney disease research. Kidney organoids may offer a better way forward.
Page 1 of 1 - 9 Total Items
